CRM
CNMD icon

Cramer Rosenthal McGlynn’s CONMED CNMD Stock Holding History

Cramer Rosenthal McGlynn’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-154,591
Closed -$12.2M – 139
2018
Q3 		$12.2M Sell
154,591
-280,048
-64% -$21.7M 0.23% 109
2018
Q2 		$31.8M Sell
434,639
-361,855
-45% -$24.6M 0.57% 72
2018
Q1 		$50.4M Sell
796,494
-224,275
-22% -$13.4M 0.82% 54
2017
Q4 		$52M Sell
1,020,769
-4,515
-0.4% -$235K 0.84% 50
2017
Q3 		$53.8M Sell
1,025,284
-42,560
-4% -$2.14M 0.86% 42
2017
Q2 		$54.4M Buy
1,067,844
+75,055
+8% +$3.71M 0.83% 48
2017
Q1 		$44.1M Sell
992,789
-26,905
-3% -$1.16M 0.67% 67
2016
Q4 		$45M Sell
1,019,694
-72,280
-7% -$3.07M 0.67% 68
2016
Q3 		$43.7M Buy
1,091,974
+24,984
+2% +$1.06M 0.67% 66
2016
Q2 		$50.9M Sell
1,066,990
-13,450
-1% -$569K 0.82% 39
2016
Q1 		$45.3M Buy
1,080,440
+16,710
+2% +$656K 0.71% 62
2015
Q4 		$46.9M Buy
1,063,730
+76,953
+8% +$3.34M 0.7% 60
2015
Q3 		$47.1M Sell
986,777
-4,412
-0.4% -$242K 0.64% 61
2015
Q2 		$57.8M Sell
991,189
-51,525
-5% -$2.78M 0.71% 53
2015
Q1 		$52.6M Sell
1,042,714
-65,825
-6% -$3.23M 0.59% 71
2014
Q4 		$49.8M Buy
1,108,539
+149,632
+16% +$6.27M 0.51% 79
2014
Q3 		$35.3M Sell
958,907
-118,237
-11% -$4.69M 0.35% 98
2014
Q2 		$47.6M Sell
1,077,144
-161,884
-13% -$7.34M 0.38% 97
2014
Q1 		$53.8M Sell
1,239,028
-26,274
-2% -$1.17M 0.41% 95
2013
Q4 		$53.8M Buy
1,265,302
+115,013
+10% +$4.37M 0.38% 94
2013
Q3 		$39.1M Sell
1,150,289
-104,425
-8% -$3.41M 0.29% 112
2013
Q2 		$39.2M Buy
+1,254,714
New +$40.7M 0.3% 115

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cramer Rosenthal McGlynn's CNMD Position: Q4 2018 in Review

Cramer Rosenthal McGlynn sold out of CONMED (CNMD) in Q4 2018, closing a stake of 154,591 shares — an estimated $12.2M sold.

Cramer Rosenthal McGlynn first reported a position in CNMD in Q2 2013 and held it in 22 quarters. The position peaked at $57.8M in Q2 2015. 207 funds tracked by Wall St. Rank hold CNMD as of Q4 2018.

  • Cramer Rosenthal McGlynn reported no remaining CONMED position as of Q4 2018 after selling out during the quarter.
  • Cramer Rosenthal McGlynn sold 154,591 CONMED shares in Q4 2018, an estimated $12.2M.
  • Cramer Rosenthal McGlynn first reported a position in CONMED in Q2 2013 and held it in 22 quarters.
  • Cramer Rosenthal McGlynn's CONMED position peaked at $57.8M in Q2 2015.
  • 207 funds tracked by Wall St. Rank held CONMED as of Q4 2018.

Based on Cramer Rosenthal McGlynn's 13F filing for Q4 2018, filed 13 Feb 2019.